New cancer clinical trial: A Clinical Performance Study to Validate the Use of Novel Molecular Diagnostic Assays for the Detection of Cancer Biomarkers in Peripheral Blood and Primary Tumor Tissue Samples of Patients With Metastatic ER+/HER2- Breast Cancer

Published on: July 21, 2020 at 07:00PM
Condition:   Breast Cancer
Intervention:   Diagnostic Test: PIK3CA kit
Sponsors:   Pharmassist Ltd;   University of Athens
Recruiting